1-7 of 7
Ann Forslund
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative Analysis of sSLAMF7, sBCMA, and M-Protein As Prognostic, Predictive, and Pharmacodynamic Biomarkers in Relapsed/Refractory Multiple Myeloma Treated with Pomalidomide and Dexamethasone +/- Elotuzumab

Ann Forslund, PhD, Hao Tang, Chunzhe Duan, Mihaela Popa-McKiver, PhD, James R. Berenson, MD, Michael Robbins, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1853.
https://doi.org/10.1182/blood-2019-128760
Published: 2019
Journal Articles

Enhanced Efficacy of the SYK Inhibitor Entospletinib and Chemotherapy in Infant Acute Lymphoblastic Leukemia

Joseph Patrick Loftus, BS, Anella Yahiaoui, BS, Feng Shen, MDPhD, David Lopez, Igor Mikaelian, DVM, Patrick A Brown, MD, Stacey Tannheimer, PhD, Ann Forslund, PhD, Sarah K Tasian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2611.
https://doi.org/10.1182/blood.V130.Suppl_1.2611.2611
Published: 2017
Journal Articles

Ex Vivo Activity Profile of the CD123xCD3 Duobody® Antibody JNJ-63709178 Against Primary Acute Myeloid Leukemia Bone Marrow Samples

Ann Forslund, Khaja Syed, Amy Axel, Ronan McDaid, Yingzhe Li, Juan Ballesteros, Francois Gaudet, Ricardo M. Attar, Mark Salvati, Fei Huang, Kate Sasser
Journal: Blood
Blood (2016) 128 (22): 2875.
https://doi.org/10.1182/blood.V128.22.2875.2875
Published: 2016
Journal Articles

Preclinical Evaluation of CSL362/JNJ-56022473 Single Agent in in Vitro Assays

Khaja Syed, M.S., Christine Pietsch, PhD, Amy Axel, Ann Forslund, PhD, Kate Sasser, PhD, Mark Salvati, PhD
Journal: Blood
Blood (2015) 126 (23): 4946.
https://doi.org/10.1182/blood.V126.23.4946.4946
Published: 2015
Journal Articles

Preclinical Evaluation of CSL362/JNJ-56022473 in Combination with Decitabine or Azacitidine in in Vitro Assays

Khaja Syed, M.S., Christine Pietsch, PhD, Amy Axel, Ann Forslund, PhD, Kate Sasser, PhD, Mark Salvati, PhD
Journal: Blood
Blood (2015) 126 (23): 1370.
https://doi.org/10.1182/blood.V126.23.1370.1370
Published: 2015
Journal Articles

Phase 1b Dose Escalation Study Of Oral Quisinostat, a Histone Deacetylase Inhibitor (HDACi), In Combination With Velcade (Bortezomib) and Dexamethasone For Patients With Relapsed Multiple Myeloma (MM)

Philippe Moreau, MD, Thierry Facon, MD, Cyrille Touzeau, MD, Lotfi Benboubker, MD, Martine Delain, MD, Julie Badamo-Dotzis, PhD, Charles Phelps, Christopher Doty, Hans Smit, PhD, Nele Fourneau, MD, Ann Forslund, Peter Hellemans, MD, Xavier Leleu, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1932.
https://doi.org/10.1182/blood.V122.21.1932.1932
Published: 2013
Journal Articles

Phase 2 Multicenter Trial of Oral Quisinostat, a Histone Deacetylase Inhibitor, in Patients with Previously Treated Stage IB-IVA Cutaneous T-Cell Lymphoma

Fiona Child, MD, Pablo Ortiz Romero, Prof., Rute Alvarez, MD, Martine Bagot, Rudolf Stadler, MD, Michael Weichenthal, MD, Rosario Alves, MD, Maria Grazia Bernengo, Prof., Marie Beylot-Barry, Prof., Richard Cowan, Larisa J. Geskin, MD, Amparo Pérez Ferriols, Peter Hellemans, MD, Yusri Elsayed, MD, PhD, Charles Phelps, Ann Forslund, Makio Kamida, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2012) 120 (21): 3676.
https://doi.org/10.1182/blood.V120.21.3676.3676
Published: 2012